Don't know why....BDZ has messaged me and assured me its not him.  I wasn't going on about communications or anything.  Merely discussing the reality of Resverlogix needing to get the attention of Fund Manager types and how the bar is set higher for a small Canadian Biotech than it is for the Pfizers of the world.  

In reply to Koo....no I'm not frustrated with this, merely realistic.  It is what it is.  Just because the bar is set higher that doesn't mean we can't clear it.  Unfortunatley it does perhaps mean more dilution than we'd like to see in the short term...but if Apabetalone ends up being the blockbuster we all see to think it could be, then that's the price of admission I guess.  

Happy Sunday everyone...